BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17654496)

  • 1. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
    Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
    Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP
    Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
    BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
    Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
    Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
    Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
    Yousef GM; Magklara A; Diamandis EP
    Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells.
    Lu W; Zhou D; Glusman G; Utleg AG; White JT; Nelson PS; Vasicek TJ; Hood L; Lin B
    Prostate; 2006 Jun; 66(9):936-44. PubMed ID: 16541416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues.
    Petraki CD; Gregorakis AK; Papanastasiou PA; Karavana VN; Luo LY; Diamandis EP
    Prostate Cancer Prostatic Dis; 2003; 6(3):223-7. PubMed ID: 12970725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray.
    Bull JH; Ellison G; Patel A; Muir G; Walker M; Underwood M; Khan F; Paskins L
    Br J Cancer; 2001 Jun; 84(11):1512-9. PubMed ID: 11384102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue.
    Paradis V; Dargère D; Laurendeau I; Benoît G; Vidaud M; Jardin A; Bedossa P
    J Pathol; 1999 Oct; 189(2):213-8. PubMed ID: 10547577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer.
    Bostwick DG; Alexander EE; Singh R; Shan A; Qian J; Santella RM; Oberley LW; Yan T; Zhong W; Jiang X; Oberley TD
    Cancer; 2000 Jul; 89(1):123-34. PubMed ID: 10897009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice-site genetic polymorphism of the human kallikrein 12 (KLK12) gene correlates with no substantial expression of KLK12 protein having serine protease activity.
    Shinmura K; Tao H; Yamada H; Kataoka H; Sanjar R; Wang J; Yoshimura K; Sugimura H
    Hum Mutat; 2004 Sep; 24(3):273-4. PubMed ID: 15300858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel prostate cancer-associated tumor antigen.
    Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC
    Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
    Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
    Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.